Beclometasone Oral - DOR BioPharma: Beclomethasone Oral - DOR BioPharma.
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001507:Beclomethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D005767:Gastrointestinal Diseases / Q000503:physiopathology / Q000517:prevention & control; D006084:Graft Rejection / Q000503:physiopathology / Q000517:prevention & control*; D006086:Graft vs Host Disease / Q000503:physiopathology / Q000517:prevention & control*; D019337:Hematologic Neoplasms / Q000150:complications / Q000628:therapy; D006801:Humans; D008171:Lung Diseases / Q000209:etiology / Q000517:prevention & control; D033581:Stem Cell Transplantation / Q000009:adverse effects; D013608:Tablets, Enteric-Coated
D000893:Anti-Inflammatory Agents; D013608:Tablets, Enteric-Coated; D001507:Beclomethasone